A predicted 40 percent decrease in SAEs with a 15 mg. reduction in dose while maintaining efficacy is fantastic news if true.
ARIA’s poster did not include the phrase, while maintaining efficacy in the statement you referenced; you added that. Moreover, the statement in question pertains to arterial thrombotic SAEs, not SAEs in general.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.